Preventing catheter-related infections with antibiotic lock solutions: Are we spoilt for choice?

Nephrology

Volumn 11, Issue 4, 2006, Pages 297-298

  Dogra, Gursharan ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CITRIC ACID; EDETIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; TAUROLIDINE; VANCOMYCIN;

BIOFILM; CATHETER INFECTION; CLINICAL TRIAL; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; EDITORIAL; EVALUATION; HEMODIALYSIS; HUMAN; OTOTOXICITY; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RISK REDUCTION; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERIZATION; HUMANS; RENAL DIALYSIS;

EID: 33746108117     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00582.x     Document Type: Editorial

References (20)

1. Marshall M, McDonald S, Excell L, Livingstone B, Shtangey V. Haemodialysis. In: McDonald S, Excell L (eds). ANZDATA Registry Report 2005, Australia and New Zealand Dialysis and Transplant Registry. Adelaide, SA. 2005; pp. 76-9.
2. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int. 1999; 56: 1-17.
3. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002; 62: 620-26.
4. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J. Am. Soc. Nephrol. 2004; 15: 477-86.
5. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int. 2005; 68: 311-18.
6. Saxena AK, Panhotra BR. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: A case controlled study. J. Nephrol. 2005; 18: 755-63.
7. Saxena AK, Panhotra BR, Sundaram DS, Morsy MNF, Al-Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomized double-blind clinical trial. Nephrology 2006; 11: 299-305.
8. Mermel LA. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 2000; 132: 391-402.
9. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14: 427-32.
10. Dogra GK, Herson H, Hutchison B et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J. Am. Soc. Nephrol. 2002; 13: 2133-9.
11. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 2004; 66: 801-5.
12. Kim SH, Song KI, Chang JW et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trial. Kidney Int. 2006; 69: 161-4.
13. Carratala J, Niubo J, Fernandez-Sevilla A et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob. Agents Chemother. 1999; 43: 2200-204.
14. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol. Dial. Transplant. 2004; 19: 1546-51.
15. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect. Control Hosp. Epidemiol. 2005; 26: 520-24.
16. Weijmer MC, van den Dorpel MA, Van de Ven PJ et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol. 2005; 16: 2769-77.
17. Butterly DW, Schwab SJ. Dialysis access infections. Curr. Opin. Nephrol. Hypertens. 2000; 9: 631-5.
18. Saxena AK, Panhotra BR. Prevention of catheter-related bloodstream infections: An appraisal of developments in designing an infection-resistant 'dream dialysis-catheter'. Nephrology (Carlton) 2005; 10: 240-48.
19. FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant [Internet]. FDA Talk Paper. Food and Drug Administration, US Department of Health and Human Services, Public Health Service. 2000. [Cited 14 April 2000.] Available from URL: http://www.fda.gov/bbs/topics/ANSWERS/ANS01009.html.
20. Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif. 2001; 19: 251-4.